lactic acid has been researched along with ST Elevation Myocardial Infarction in 7 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
ST Elevation Myocardial Infarction: A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hyperuricemia was defined as a serum uric acid level >7 mg/dL for males and >6 mg/dL for females." | 4.12 | Interaction between Hyperuricemia and Admission Lactate Increases the Risk of Acute Kidney Injury in Patients with ST-Segment Elevation Myocardial Infarction. ( He, Y; Hong, X; Huang, W; Liang, D; Lin, Q; Shan, P; Wang, D; Zhou, X; Zhu, Q, 2022) |
| "Patients with STEMI treated using PCLeB have reported positive outcomes." | 3.01 | Postconditioning with Lactate-Enriched Blood for Reducing Lethal Reperfusion Injury in Humans. ( Koyama, T, 2023) |
| "We recommend lactate measurement in STEMI-subjects, especially when signs of compromised hemodynamics are present." | 2.90 | Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction. ( Bang, LE; Frikke-Schmidt, R; Frydland, M; Goetze, JP; Hansen, R; Hassager, C; Henriques, JPS; Holmvang, L; Jensen, LO; Kjaergaard, J; Lindholm, MG; Møller, JE; Møller-Helgestad, OK; Obling, L; Ouweneel, DM; Ravn, HB; Thomsen, JH; Udesen, NLJ; Wiberg, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y | 1 |
| Wang, D | 1 |
| Zhou, X | 1 |
| Zhu, Q | 1 |
| Lin, Q | 1 |
| Hong, X | 1 |
| Huang, W | 1 |
| Shan, P | 1 |
| Liang, D | 1 |
| Koyama, T | 2 |
| Frydland, M | 1 |
| Møller, JE | 2 |
| Wiberg, S | 1 |
| Lindholm, MG | 2 |
| Hansen, R | 1 |
| Henriques, JPS | 1 |
| Møller-Helgestad, OK | 1 |
| Bang, LE | 1 |
| Frikke-Schmidt, R | 1 |
| Goetze, JP | 1 |
| Udesen, NLJ | 1 |
| Thomsen, JH | 1 |
| Ouweneel, DM | 1 |
| Obling, L | 1 |
| Ravn, HB | 1 |
| Holmvang, L | 2 |
| Jensen, LO | 2 |
| Kjaergaard, J | 1 |
| Hassager, C | 2 |
| Udesen, NJ | 1 |
| Eiskjær, H | 1 |
| Schäfer, A | 1 |
| Werner, N | 1 |
| Terkelsen, CJ | 1 |
| Junker, A | 1 |
| Schmidt, H | 1 |
| Wachtell, K | 1 |
| Thiele, H | 1 |
| Engstrøm, T | 1 |
| Rohm, CL | 1 |
| Gadidov, B | 1 |
| Leitson, M | 1 |
| Ray, HE | 1 |
| Prasad, R | 1 |
| Akima, T | 1 |
| Munakata, M | 1 |
| Shibata, M | 1 |
| Moritani, K | 1 |
| Kanki, H | 1 |
| Ishikawa, S | 1 |
| Mitamura, H | 1 |
| Davierwala, PM | 1 |
| Leontyev, S | 1 |
| Verevkin, A | 1 |
| Rastan, AJ | 1 |
| Mohr, M | 1 |
| Bakhtiary, F | 1 |
| Misfeld, M | 1 |
| Mohr, FW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial[NCT01633502] | 360 participants (Actual) | Interventional | 2012-12-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for lactic acid and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
Postconditioning with Lactate-Enriched Blood for Reducing Lethal Reperfusion Injury in Humans.
Topics: Humans; Lactic Acid; Myocardial Reperfusion Injury; ST Elevation Myocardial Infarction | 2023 |
2 trials available for lactic acid and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction.
Topics: Aged; Blood Pressure; Disease-Free Survival; Female; Humans; Lactic Acid; Male; Middle Aged; Shock, | 2019 |
Rationale and design of DanGer shock: Danish-German cardiogenic shock trial.
Topics: Aged; Blood Pressure; Cause of Death; Female; Guideline Adherence; Heart-Assist Devices; Humans; Lac | 2019 |
4 other studies available for lactic acid and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
Interaction between Hyperuricemia and Admission Lactate Increases the Risk of Acute Kidney Injury in Patients with ST-Segment Elevation Myocardial Infarction.
Topics: Acute Kidney Injury; Female; Humans; Hyperuricemia; Lactic Acid; Male; Risk Factors; ST Elevation My | 2022 |
Predictors of Mortality and Outcomes of Acute Severe Cardiogenic Shock Treated with the Impella Device.
Topics: Aged; Assisted Circulation; Carbon Dioxide; Cardiotonic Agents; Female; Heart Arrest; Heart-Assist D | 2019 |
Absence of reperfusion-induced arrhythmia in patients with ST-segment elevation myocardial infarction treated using postconditioning with lactate-enriched blood.
Topics: Aged; Arrhythmias, Cardiac; Female; Humans; Ischemic Postconditioning; Lactic Acid; Male; Myocardial | 2016 |
Temporal Trends in Predictors of Early and Late Mortality After Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction.
Topics: Age Factors; Aged; Coronary Artery Bypass; Disease-Free Survival; Extracorporeal Membrane Oxygenatio | 2016 |